PCOS root causes functional

The PCOS Puzzle: Using Functional Testing to Address Root Causes and Restore Balance

Author: Rohan Smith | Functional Medicine Practitioner | Adelaide, SA

Quick Answer

Polycystic Ovary Syndrome (PCOS) is a complex hormonal condition that affects far more than reproductive health alone. While irregular menstrual cycles, acne, and fertility challenges are well-recognised features, PCOS is also closely associated with insulin resistance, low-grade inflammation, and disrupted stress and sex hormone regulation (1–3). Together, these mechanisms can contribute to fatigue, weight gain, mood changes, and an increased long-term risk of cardiometabolic disease.

A functional medicine approach focuses on identifying and addressing the biological drivers contributing to PCOS, rather than suppressing symptoms in isolation. This may involve targeted lifestyle interventions alongside functional testing to assess insulin signalling, androgen activity, cortisol patterns, and hormone metabolism. When interpreted appropriately, these insights can help guide personalised nutrition, lifestyle, and support strategies aimed at improving hormonal balance and metabolic resilience over time (4–6).

PCOS: More Than Just a Reproductive Condition

PCOS is typically diagnosed based on a combination of ovulatory dysfunction, hyperandrogenism, and polycystic ovarian morphology. Increasingly, research suggests that PCOS is best understood as a multisystem metabolic–endocrine condition rather than a purely gynaecological disorder (2,3).

Many women with PCOS experience symptoms beyond the reproductive system, including persistent fatigue, difficulty managing weight, mood disturbances, and sugar cravings. These features often reflect underlying disturbances in insulin signalling, inflammatory pathways, and neuroendocrine stress regulation, which are commonly explored in patients presenting with chronic fatigue.

Key Mechanisms Involved in PCOS

  • Insulin resistance: Reduced cellular responsiveness to insulin can lead to compensatory hyperinsulinaemia, which may stimulate excess ovarian androgen production and disrupt ovulation (3,7).
  • Chronic low-grade inflammation: Inflammatory signalling appears more frequently in PCOS and may worsen insulin resistance and hormonal dysregulation (8,9). This inflammatory burden is often influenced by gut health and the gut microbiome.
  • Hormonal imbalance: Elevated androgens and altered luteinising hormone (LH) to follicle-stimulating hormone (FSH) ratios can interfere with normal follicular development and ovulation (2).

How Functional Testing Can Support a Root-Cause Approach

Functional medicine testing aims to provide additional physiological context alongside standard medical assessment. These tools are not diagnostic for PCOS, but may offer useful insight into patterns that influence symptom severity, metabolic health, and hormonal regulation.

DUTCH Hormone Testing

The Dried Urine Test for Comprehensive Hormones (DUTCH) evaluates sex hormones, their metabolites, and diurnal cortisol patterns. In women with PCOS, DUTCH testing may help explore:

  • Cortisol rhythm and stress physiology
  • Oestrogen metabolism pathways
  • Relative progesterone output
  • Patterns of androgen production and clearance

When clinically appropriate, comprehensive hormone testing such as the DUTCH Complete test can be used to support a personalised care plan. All results must be interpreted within the broader clinical picture and are used to inform care strategies rather than replace conventional diagnostic criteria (10–12).

A Multi-Layered Strategy for Managing PCOS

Effective PCOS management typically requires a personalised and multi-factorial strategy that addresses metabolic, inflammatory, and lifestyle contributors concurrently.

Nutrition Support

  • Low-glycaemic dietary patterns: Supporting stable blood glucose levels may help reduce insulin demand and downstream androgen excess (7).
  • Anti-inflammatory foods: Diets rich in vegetables, omega-3 fats, and fibre may help modulate inflammatory signalling (8,13).
  • Reducing ultra-processed foods: Excess refined carbohydrates and added sugars may exacerbate insulin resistance and metabolic stress.

Nutrient Support (When Clinically Indicated)

  • Inositol: May support insulin sensitivity and ovulatory function in some women with PCOS (14,15).
  • Omega-3 fatty acids: Associated with improvements in inflammatory markers and lipid profiles (13,16).
  • Magnesium: Plays a role in glucose metabolism, nervous system regulation, and stress resilience (17).
  • Vitamin D: Low vitamin D status is commonly observed in PCOS and may be associated with metabolic and reproductive features (18,19).

Lifestyle Interventions

  • Regular physical activity: Both resistance training and aerobic exercise may improve insulin sensitivity and cardiometabolic health (20).
  • Stress regulation: Mind-body practices can support cortisol balance and neuroendocrine function, which may overlap with thyroid and stress-related patterns discussed in thyroid health.
  • Sleep quality: Consistent, restorative sleep is essential for hormonal regulation and glucose control.

When to Consider Functional Assessment

Functional assessment may be appropriate for women with PCOS who continue to experience symptoms despite standard interventions, or where metabolic features such as insulin resistance, fatigue, or stress intolerance are prominent. Testing should always be guided and interpreted by a qualified practitioner.

Frequently Asked Questions

What are the main underlying drivers of PCOS beyond reproductive symptoms?

PCOS is increasingly understood as a multisystem metabolic–endocrine condition. Common underlying drivers include insulin resistance, low-grade chronic inflammation, and disrupted stress and sex hormone regulation. These factors can influence ovulation, androgen production, energy levels, mood, and long-term cardiometabolic risk, extending well beyond reproductive health alone.

How can functional testing support a personalised approach to PCOS?

Functional testing does not diagnose PCOS, but it may help identify physiological patterns that influence symptom severity and metabolic health. Tests such as comprehensive hormone panels can provide insight into cortisol rhythms, androgen activity, and hormone metabolism. When interpreted alongside clinical assessment, these findings may help guide individualised nutrition, lifestyle, and support strategies.

Can PCOS symptoms improve without medication?

While PCOS is considered a chronic condition, many symptoms and associated metabolic risk factors may improve with appropriate lifestyle and nutritional support. Strategies that address insulin sensitivity, inflammation, stress regulation, sleep quality, and overall metabolic health are commonly used alongside, or sometimes instead of, medication depending on individual circumstances and clinical guidance.

Key Insights

  • PCOS is a multisystem metabolic–endocrine condition.
  • Insulin resistance and inflammation play central roles.
  • Functional testing can support personalised care when used appropriately.
  • Long-term management focuses on metabolic and hormonal resilience.

Take the First Step

A comprehensive PCOS strategy involves integrating medical assessment, lifestyle interventions, and targeted functional insights. Personalised care focuses on supporting long-term hormonal and metabolic health rather than short-term symptom suppression alone.

If you are based in Adelaide and seeking a personalised, evidence-informed approach to PCOS care, functional medicine support may help identify contributing factors and guide sustainable health strategies through Elemental Health and Nutrition.

Book a free 15min Discovery Call

References

  1. Azziz R et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016 Apr 28;2:16057. https://doi.org/10.1038/nrdp.2016.57
  2. Teede HJ et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018 Sep 1;33(9):1602-1618. https://doi.org/10.1093/humrep/dey256
  3. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997 Dec;18(6):774-800. https://doi.org/10.1210/edrv.18.6.0318
  4. Diamanti-Kandarakis E et al. Pathophysiology and types of dyslipidemia in PCOS. Trends Endocrinol Metab. 2007 Mar;18(2):72-8. https://doi.org/10.1016/j.tem.2006.12.002
  5. Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016 Oct;37(5):467-520. https://doi.org/10.1210/er.2015-1104
  6. Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018 May;14(5):270-284. https://doi.org/10.1038/nrendo.2018.24
  7. Legro RS et al. Insulin resistance in polycystic ovary syndrome: concepts, measurement, genetics and treatment. Endocrinol Metab Clin North Am. 2011 Mar;40(1):1-17. https://doi.org/10.1016/j.ecl.2010.10.003
  8. González F. Nutrient-induced inflammation in polycystic ovary syndrome: a potential role for the gut microbiome. Reprod Sci. 2012 Nov;19(11):1155-63. https://doi.org/10.1177/1933719112459229
  9. Repaci A et al. Chronic inflammation and PCOS: the role of adipokines. Int J Mol Sci. 2011;12(12):9284-93. https://doi.org/10.3390/ijms12129284
  10. Newman M et al. Dried urine hormone testing methodology: validation and clinical utility. Steroids. 2019 Nov;151:108457. https://doi.org/10.1016/j.steroids.2019.108457
  11. Stanczyk FZ. Measurement of androgens in women. Semin Reprod Med. 2006 Mar;24(2):78-85. https://doi.org/10.1055/s-2006-931797
  12. Auchus RJ. Steroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic. J Steroid Biochem Mol Biol. 2017 Jan;165(Pt A):71-78. https://doi.org/10.1016/j.jsbmb.2016.02.002
  13. Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr. 2002 Dec;21(6):495-505. https://doi.org/10.1080/07315724.2002.10719248
  14. Unfer V et al. Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials. Gynecol Endocrinol. 2017;33(11):875-883. https://doi.org/10.1080/09513590.2017.1336174
  15. Pizzo A et al. Myo-inositol in the treatment of polycystic ovary syndrome. Eur Rev Med Pharmacol Sci. 2014;18(13):1896-903. https://pubmed.ncbi.nlm.nih.gov/25010644/
  16. Mohammadi E et al. Omega-3 supplementation effects on polycystic ovary syndrome symptoms and metabolic syndrome. J Ovarian Res. 2012 Jul 16;5(1):15. https://doi.org/10.1186/1757-2215-5-15
  17. Barbagallo M et al. Magnesium and insulin sensitivity in overweight/obese women with PCOS. Curr Pharm Des. 2014;20(31):5031-7. https://doi.org/10.2174/1381612820666140630100125
  18. Wehr E et al. Association of vitamin D status with serum androgen levels in men. Eur J Endocrinol. 2009 Dec;161(6):947-52. https://doi.org/10.1530/EJE-09-0577
  19. Irani M et al. Vitamin D deficiency is prevalent among infertile women and is associated with metabolic syndrome markers. Fertil Steril. 2014 Jun;101(6):1674-80. https://doi.org/10.1016/j.fertnstert.2014.02.030
  20. Harrison CL et al. Exercise therapy in polycystic ovary syndrome: a systematic review. Hum Reprod Update. 2011 Mar-Apr;17(2):171-83. https://doi.org/10.1093/humupd/dmq045
  21. Chrousos GP. Stress and endocrine regulation. Endocrinol Metab Clin North Am. 2000 Jun;29(2):xv-xvi. https://doi.org/10.1016/s0889-8529(05)70132-9